RLFTF ran from .04 to .95 on massive volume and momentum hauling super duty float of 1.2 bil now reporting 1.6 bil as of late July. All three had good to Monster runs but now its time to turn our attention to the long haul. Long hauler drugs that is. BPSR drug Zofin got similar approval that Aviptadil did on the same day. But unlike RLFTF BPSR has huge insider ownership and huge insider buying. They are not pulling value out of it as fast as they can like RLFTF with its massive massive did I say MASSIVE DILUTION. BPSR is not diluting.
Check out the insider actions which speak louder than BS words.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.